MMV048   Click here for help

GtoPdb Ligand ID: 9726

Synonyms: MMV390048
Antimalarial Ligand
Compound class: Synthetic organic
Comment: MMV048 is the optimised lead compound for the 2-aminopyridines, a class of small molecules with promising antimalarial activity [4].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 94.32
Molecular weight 393.08
XLogP 3.84
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Nc1ncc(cc1c1ccc(nc1)C(F)(F)F)c1ccc(cc1)S(=O)(=O)C
Isomeric SMILES Nc1ncc(cc1c1ccc(nc1)C(F)(F)F)c1ccc(cc1)S(=O)(=O)C
InChI InChI=1S/C18H14F3N3O2S/c1-27(25,26)14-5-2-11(3-6-14)13-8-15(17(22)24-10-13)12-4-7-16(23-9-12)18(19,20)21/h2-10H,1H3,(H2,22,24)
Guide to Malaria Pharmacology Comments
Phenotypic whole cell high-throughput screening has identified the 2-aminopyridines as a class of small molecules with promising antimalarial activity [4]. MMV048, the optimised lead compound from this class, has activity against all lifecycle stages of the Plasmodium parasite, with the exception of late stage hypnozoites [3]. UCT943 is another compound from this screen, that was being developed as a back-up for MMV048, but was withdrawn due to preclinical toxicity concerns.
MMV048 has progressed to clinical evaluation and was awarded MMV Project of the Year award (2012).

Potential Target/Mechanism Of Action: Genomic and chemoproteomic experiments provide significant evidence that the molecular target of MMV048 is the Plasmodium lipid kinase, phosphatidylinositol 4-kinase (PfPI4K) [3].
Target Candidate Profiles
Profile Intended Use Target Stage Comment References
TCP-1 reduce parasite burden asexual blood stages
TCP-4 chemoprotection hepatic schizonts
TCP-5 transmission reduction gametocytes